You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucinous Ovarian cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Ovarian Cancer Trial in Houston (Cytoreductive surgery)

Recruiting
  • Ovarian Cancer
  • Cytoreductive surgery
  • Houston, Texas
    MD Anderson Cancer Center
Jul 28, 2022

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

oncRNA Stratification of Cancer by Size and Stage

Not yet recruiting
  • Kidney Cancer
  • +32 more
  • Exai oncRNA blood test
  • (no location specified)
Apr 27, 2023

The Immune Landscape of Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • Collection of tumor samples, blood and vaginal and rectal swabs
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland
Aug 2, 2023

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021

PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor

Not yet recruiting
  • PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
  • blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
  • (no location specified)
Aug 17, 2023

Oocyte Freezing for Fertility Preservation in Benign Ovarian

Recruiting
  • Endometriosis
  • +2 more
    • Lille, France
      Hop Jeanne de Flandre Chu Lille
    Dec 13, 2022

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • New Haven, Connecticut
    • +1 more
    Jan 11, 2023

    Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

    Not yet recruiting
    • Secondary Malignant Neoplasm of Retroperitoneum
    • +2 more
    • Intestinal, Multivisceral or Modified Multivisceral Transplantation
    • +3 more
    • Cleveland, Ohio
      Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
    Oct 10, 2023

    Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

    Terminated
    Has Results
    • Mucinous Adenocarcinoma of the Colon
    • Mucinous Adenocarcinoma of the Rectum
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Sep 26, 2022

    Genetics of Appendix Cancer Study

    Recruiting
    • Appendix Cancer
    • +14 more
    • Genetic profiling
    • Retrospective tissue procurement
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Feb 8, 2023

    Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

    Not yet recruiting
    • Recurrent Ovarian Cancer
    • (no location specified)
    Jan 27, 2023

    High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

    Not yet recruiting
    • High Grade Serous Ovarian Cancer (HGSOC)
    • FAPI PET CT
    • (no location specified)
    Jul 20, 2023

    Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in

    Recruiting
    • Fallopian Tube Mucinous Adenocarcinoma
    • +49 more
    • Cediranib Maleate
    • +5 more
    • Anchorage, Alaska
    • +373 more
    Aug 17, 2022

    Shanghai Ovarian Cancer and Family Care Project

    Recruiting
    • Ovarian Cancer
      • Shanghai, Shanghai, China
        Shanghai first maternity and infant hospital
      Oct 31, 2023

      Transforming Ovarian Cancer Diagnostic Pathways

      Not yet recruiting
      • Ovarian Cancer
        • Birmingham, United Kingdom
        • +2 more
        Nov 10, 2023

        Epithelial Ovarian Cancer: A Retrospective Study

        Recruiting
        • Epithelial Ovarian Cancer
        • Hematologic features
        • Shanghai, Shanghai, China
          Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
        Oct 16, 2023